These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10385451)

  • 1. Amprenavir approved for HIV treatment.
    Miller SL
    Am J Health Syst Pharm; 1999 Jun; 56(11):1057-8. PubMed ID: 10385451
    [No Abstract]   [Full Text] [Related]  

  • 2. Amprenavir approved.
    STEP Perspect; 1999; 99(2):8. PubMed ID: 11366753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amprenavir approved.
    AIDS Patient Care STDS; 1999 Jul; 13(7):438. PubMed ID: 10870601
    [No Abstract]   [Full Text] [Related]  

  • 4. Amping amprenavir with ritonavir.
    TreatmentUpdate; 2001; 12(12):10. PubMed ID: 11570075
    [No Abstract]   [Full Text] [Related]  

  • 5. Amprenavir made available through early access program.
    AIDS Patient Care STDS; 1998 Dec; 12(12):939-40. PubMed ID: 11362067
    [No Abstract]   [Full Text] [Related]  

  • 6. Amprenavir, new protease inhibitor, approved.
    James JS
    AIDS Treat News; 1999 May; (No 318):1-3. PubMed ID: 11366454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amprenavir (Agenerase) receives FDA approval. Food and Drug Administration.
    Highleyman L
    BETA; 1999 Apr; 12(2):3. PubMed ID: 11366693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded access.
    Proj Inf Perspect; 1999 Apr; (27):13. PubMed ID: 11366730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower dose of ritonavir approved for use with fosamprenavir.
    Sax PE
    AIDS Clin Care; 2007 Dec; 19(12):106. PubMed ID: 18399004
    [No Abstract]   [Full Text] [Related]  

  • 10. Agenerase approved by FDA.
    Gaylord G
    Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug approval.
    AIDS Policy Law; 1999 Apr; 14(8):12. PubMed ID: 11366532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lame duck, a dark horse, and a goat.
    Huff B
    GMHC Treat Issues; 2005; 19(5-6):4-5. PubMed ID: 16193576
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA notifications. FDA approves NDA for Lexiva.
    AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
    [No Abstract]   [Full Text] [Related]  

  • 14. Trials for protease failure.
    Posit Aware; 1998; 9(5):16-7. PubMed ID: 11365884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drugs: amprenavir and abacavir.
    TreatmentUpdate; 1998 Apr; 10(2):3-4. PubMed ID: 11365435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amprenavir: a new protease inhibitor nears approval.
    Highleyman L
    BETA; 1999 Jan; 12(1):8-9. PubMed ID: 11367244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA notifications. FDA approves new formulation of Lexiva.
    AIDS Alert; 2007 Aug; 22(8):90-1. PubMed ID: 17768778
    [No Abstract]   [Full Text] [Related]  

  • 18. Drifting agenda for federal treatment research.
    Huff B
    GMHC Treat Issues; 2001 May; 15(5):1-4. PubMed ID: 11548299
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA approves new dosing for amprenavir and ritonavir combination.
    AIDS Treat News; 2002 Mar; (378):6-7. PubMed ID: 11965920
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA notifications. FDA OKs new pediatric dosing for darunavir.
    AIDS Alert; 2009 Feb; 24(2):22-4. PubMed ID: 19222149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.